Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells

Biochemical and Biophysical Research Communications

Volumn 344, Issue 1, 2006, Pages 431-437

  Kwak, Young Don ^a   Choumkina, Elena ^a   Sugaya, Kiminobu ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Astrocytes; Differentiation; Down's syndrome; NT 2 D1; RNA interference; Stem cells; Teratocarcinoma

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AMINO ACID TRANSPORTER; AMYLOID PRECURSOR PROTEIN; ASPARTIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; STAUROSPORINE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME PHOSPHORYLATION; GLIA CELL; HUMAN; HUMAN CELL; MALE; NEURAL STEM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; EXCITATORY AMINO ACID TRANSPORTER 1; FLAVONOIDS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; RNA INTERFERENCE; STAUROSPORINE; STEM CELLS;

EID: 33646048760     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.054     Document Type: Article

References (33)

1. Sandhu J.K., Sikorska M., and Walker P.R. Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J. Neurosci. Res. 68 (2002) 604-614
2. Deb-Rinker P., Ly D., Jezierski A., Sikorska M., and Walker P.R. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J. Biol. Chem. 280 (2005) 6257-6260
3. Iacovitti L., Stull N.D., and Jin H. Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line. Brain Res. 912 (2001) 99-104
4. Sheridan K.M., and Maltese W.A. Expression of Rab3A GTPase and other synaptic proteins is induced in differentiated NT2N neurons. J. Mol. Neurosci. 10 (1998) 121-128
5. Kleppner S.R., Robinson K.A., Trojanowski J.Q., and Lee V.M. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J. Comp. Neurol. 357 (1995) 618-632
6. Bani-Yaghoub M., Felker J.M., and Naus C.C. Human NT2/D1 cells differentiate into functional astrocytes. Neuroreport 10 (1999) 3843-3846
7. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchya H., Takahashi Y., and Masuma R. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J. Antibiot. (Tokyo) 30 (1977) 275-282
8. D'Sa-Eipper C., and Roth K.A. Caspase regulation of neuronal progenitor cell apoptosis. Dev. Neurosci. 22 (2000) 116-124
9. Zhang B.F., Peng F.F., Zhang W., Shen H., Wu S.B., and Wu D.C. Involvement of cyclin dependent kinase 5 and its activator p35 in staurosporine-induced apoptosis of cortical neurons. Acta Pharmacol. Sin. 25 (2004) 1105-1111
10. Schumacher A., Arnhold S., Addicks K., and Doerfler W. Staurosporine is a potent activator of neuronal, glial, and "CNS stem cell-like" neurosphere differentiation in murine embryonic stem cells. Mol. Cell Neurosci. 23 (2003) 669-680
11. Reuter H., Bouron A., Neuhaus R., Becker C., and Reber B.F. Inhibition of protein kinases in rat pheochromocytoma (PC12) cells promotes morphological differentiation and down-regulates ion channel expression. Proc. Biol. Sci. 249 (1992) 211-216
12. Kronfeld I., Zsukerman A., Kazimirsky G., and Brodie C. Staurosporine induces astrocytic phenotypes and differential expression of specific PKC isoforms in C6 glial cells. J. Neurochem. 65 (1995) 1505-1514
13. Chan S.L., Furukawa K., and Mattson M.P. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med. 2 (2002) 167-196
14. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T.B., Giambarella U., and Nishimoto I. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272 (1996) 1349-1352
15. Small D.H., Clarris H.L., Williamson T.G., Reed G., Key B., Mok S.S., Beyreuther K., Masters C.L., and Nurcombe V. Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. J. Alzheimer's Dis. 1 (1999) 275-285
16. Caille I., Allinquant B., Dupont E., Bouillot C., Langer A., Muller U., and Prochiantz A. Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 131 (2004) 2173-2181
17. Nishimura I., Takazaki R., Kuwako K., Enokido Y., and Yoshikawa K. Upregulation and antiapoptotic role of endogenous Alzheimer amyloid precursor protein in dorsal root ganglion neurons. Exp. Cell Res. 286 (2003) 241-251
18. Burton T.R., Dibrov A., Kashour T., and Amara F.M. Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway. Brain Res. Mol. Brain Res. 108 (2002) 102-120
19. Kwak Y.D., Koike H., and Sugaya K. RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J. Pharmacol. Sci. 93 (2003) 214-217
20. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25 (2000) 1439-1451
21. Gomes F.C., Paulin D., and Moura Neto V. Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz. J. Med. Biol. Res. 32 (1999) 619-631
22. Bantounas I., Phylactou L.A., and Uney J.B. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol. 33 (2004) 545-557
23. Cho J.Y., Katz D.R., and Chain B.M. Staurosporine induces rapid homotypic intercellular adhesion of U937 cells via multiple kinase activation. Br. J. Pharmacol. 140 (2003) 269-276
24. Mills J., Laurent Charest D., Lam F., Beyreuther K., Ida N., Pelech S.L., and Reiner P.B. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17 (1997) 9415-9422
25. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
26. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
27. Rootwelt T., Dunn M., Yudkoff M., Itoh T., Almaas R., and Pleasure D. Hypoxic cell death in human NT2-N neurons: involvement of NMDA and non-NMDA glutamate receptors. J. Neurochem. 71 (1998) 1544-1553
28. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14 (1991) 453-501
29. Lesort M., Esclaire F., Yardin C., and Hugon J. NMDA induces apoptosis and necrosis in neuronal cultures. Increased APP immunoreactivity is linked to apoptotic cells. Neurosci. Lett. 221 (1997) 213-216
30. Wisniewski K.E., Dalton A.J., McLachlan C., Wen G.Y., and Wisniewski H.M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 35 (1985) 957-961
31. Haydar T.F., Nowakowski R.S., Yarowsky P.J., and Krueger B.K. Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse. J. Neurosci. 20 (2000) 4156-4164
32. Bahn S., Mimmack M., Ryan M., Caldwell M.A., Jauniaux E., Starkey M., Svendsen C.N., and Emson P. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359 (2002) 310-315
33. Liu F., Su Y., Li B., and Ni B. Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751. Exp. Cell Res. 287 (2003) 387-396